After more than two years of battling COVID-19, the unusual monkeypox outbreak is triggering another wave of anxiety.
 | | Headlines for a healthier you | | | | | Most People Don't Need the Monkeypox Vaccine |  | | After more than two years of battling COVID-19, the unusual monkeypox outbreak is triggering another wave of anxiety. But for now, health experts say that most people don't need to worry about being seriously ill with monkeypox, or getting vaccinated against it. | | Know More | | The U.S. has a stockpile of more than 100 million doses of the original smallpox vaccine, called ACAM2000. It's 85% effective at preventing monkeypox but it's only licensed for smallpox. A newer vaccine called Jynneos is available for high-risk groups. | | Feel Better | | Most people won't need a monkeypox vaccine, experts say. Some people who are exposed to the virus and those who work in high-risk environments—like laboratory and healthcare professionals—may receive the shot. | | | | | | | Many pregnant people with preeclampsia receive a missed or late diagnosis, which can delay the start of their treatment. Preeclampsia can be deadly, with higher rates of fatalities in Black women. Researchers at Stanford University are studying a blood test that may be able to detect early warning signs of preeclampsia to expedite the diagnosis process and help patients get the help they need. | | | | | | | | | The FDA oversees an extensive review process for prescription drugs, but the agency classifies dietary supplements as food—which means that a product is only removed if it's found unsafe while it's on the market. Now, the FDA may be amping up regulations slightly to increase safety information on new dietary ingredients. | | | | | |  | In Other News | | | | | | | | | | You are receiving this newsletter because you subscribed to the Verywell Health newsletter. If you wish to unsubscribe, please click here. | | A DOTDASH MEREDITH BRAND 28 Liberty Street, 7th Floor, New York, NY, 10005 | | | | | | | 
| | |
No comments:
Post a Comment